Dale E. Mais

发表

Interferometric Studies of the Extreme Binary ϵ Aurigae: Pre-Eclipse Observations

R. Stencel, M. Creech-Eakman, B. Kloppenborg, 2008, 0810.5382.

Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

M. Boehm, R. Heyman, A. Nadzan, 1995, Journal of medicinal chemistry.

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.

L. Mere, M. Elgort, M. Boehm, 1999, Chemistry & biology.

Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones.

Z. Zhang, P. Zhang, Eugene A. Terefenko, 2001, Bioorganic & medicinal chemistry letters.

Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines.

J. Edwards, L. Hamann, M. Goldman, 1998, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.

M. G. Johnson, S. Bender, L. Hamann, 1996, Journal of medicinal chemistry.

5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.

T. K. Jones, D. Mais, C. Tegley, 1999, Journal of medicinal chemistry.

5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.

J. Edwards, M. Gottardis, T. K. Jones, 1998, Journal of medicinal chemistry.

5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.

M. Gottardis, E. Kallel, T. K. Jones, 1998, Journal of medicinal chemistry.